Zifcasiran (sodium)
Zifcasiran (ADS-007) sodium is an siRNA synthetic double-stranded RNAi trigger. Zifcasiran sodium selectively target hypoxia-inducible factor-2α (HIF2α) interrupting downstream pro-oncogenic signaling in clear cell renal cell carcinoma (ccRCC) . Zifcasiran sodium engages the cell's RNAi machinery to target HIF2α (EPAS1) mRNA for degradation, thereby reducing the amount of free HIF2α mRNA available for translation[1].
Product Specifications
CAS Number
2437257-12-8
Product Name Alternative
ADS-007 (sodium) ; ARO HIF2 (sodium)
UNSPSC
12352208
Target
HIF/HIF Prolyl-Hydroxylase; Small Interfering RNA (siRNA)
Type
Oligonucleotides
Related Pathways
Epigenetics; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zifcasiran-sodium.html
Solubility
10 mM in H2O
Smiles
[Zifcasiran(sodium)]
Molecular Formula
C737H929F20N211Na52O349P43S8
Molecular Weight
21491.26
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog